Dosimetric analysis of plans using x-ray and γ-ray combination strategy for advanced cervical cancer patients with pelvic lymph node metastasis
The dual-modality system has the potential to enhance treatment outcomes in CC by optimizing tumor coverage while reducing toxicity. Future clinical trials should assess its impact on patient survival and treatment-related side effects to bridge the gap between dosimetric improvements and clinical application.
Authors
- R. Guo
- Fengwen Tang
- Yi Li (ORCID: https://orcid.org/0000-0002-6423-5744)
- Lei Xu (ORCID: https://orcid.org/0000-0001-5318-2387)
- Xuanzi Sun (ORCID: https://orcid.org/0000-0002-8182-3089)
- Jinsheng Li (ORCID: https://orcid.org/0009-0009-1900-7046)
- Jinlu Ma (ORCID: https://orcid.org/0000-0001-8672-4381)
- Zhiwei Wei
Institutions
- Sheng Jing Hospital (CN)
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-11-28
- DOI
- https://doi.org/10.1186/s12885-025-15081-0
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00